QuidelOrtho Corporation (QDEL) vs SpyGlass Pharma, Inc. Common Stock (SGP)

A side-by-side comparison of QuidelOrtho Corporation and SpyGlass Pharma, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
QuidelOrtho Corporation logo
QDEL
QuidelOrtho Corporation
$857M
$12.57HealthcareDelayed quote: Oct 6, 2026, 1:15 PM EDT
SpyGlass Pharma, Inc. Common Stock logo
SGP
SpyGlass Pharma, Inc. Common Stock
$843M
$25.20HealthcareDelayed quote: Oct 6, 2026, 1:15 PM EDT

Total return — QDEL vs SGP

growth of $100 · dividends reinvested · last 1y
QDEL -56.1% (-56.1%/yr)SGP -3.1% (-3.1%/yr)SGP compounded faster over this window
406080100Start $100$44$97
QDEL SGP

QDEL vs SGP: by the numbers

  • •QDEL is the larger company ($857M vs $843M market cap).
  • •Both run net losses; SGP's is the smaller (0.00% vs -39.20% net margin).

Metrics side by side

Valuation

MetricQDELSGP
Forward P/E16.27N/A
P/S ratio0.32N/A
P/B ratio0.483.63

Profitability

MetricQDELSGP
Gross margin44.60%0.00%
Operating margin-30.67%0.00%
Net margin-39.20%0.00%
ROE-59.07%-24.12%
ROIC-16.05%-26.54%

Growth (annualized)

MetricQDELSGP
Revenue CAGR (5Y)7.14%N/A
Total return CAGR (5Y)-38.12%N/A

Go deeper

Full QDEL analysisFull SGP analysisInteractive comparison tool

Dig into the metrics

QuidelOrtho ROESpyGlass Pharma, Inc. Common Stock ROEQuidelOrtho operating marginSpyGlass Pharma, Inc. Common Stock operating marginQuidelOrtho revenue growthSpyGlass Pharma, Inc. Common Stock revenue growthQuidelOrtho free cash flowSpyGlass Pharma, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.